Summary
Bis-β-diketonato complexes of titanium, zirconium, and hafnium were tested against autochthonous colorectal tumors in rats. The model was found to reflect the clinical situation most closely. of the compounds tested, budotitane was the most effective in terms of decrease in tumor weight and number and in increasing the lifespan of the treated animals. The therapeutic efficiency was superior to that of 5-fluorouracil, which so far has been the drug with the best activity in patients suffering from colon cancer.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- Ti(bzac)2Cl2 :
-
dichlorobis(1-phenylbutane-1,3-dionato)-titanium(IV)
- Ti(bzac)2(OEt)2, budotitane, (INN):
-
diethoxybis(1-phenylbutane-1,3-dionato)-titanium(IV)
- Zr(bzac)2Cl2 :
-
dichlorobis(1-phenulbutane-1,3-dionato)-zirconium(IV)
- Hf(bzac)2Cl2 :
-
dichlorobis(1-phenylbutane-1,3-dionato)-hafnium(IV)
- AMMN:
-
acetoxymethylmethylnitrosamine; 5-FU
- 5-FU:
-
5-Fluorouracil
- DFUR:
-
5′-deoxy-5-fluorouridine
- CPA:
-
cyclophosphamide
- cis-DDP, Cisplatin:
-
cis-diamminedichloroplatinum(II)
- INN:
-
international nonproprietary name
References
Berger, MR, Bischoff H, Hermanek P, Schmähl D (1984) Biological characterization and chemotherapy of autochthonous colorectal tumors in rats. In: Klein HO (ed) Advances in the chemotherapy of gastrointestinal cancer. Perimed-Fachbuch-Verlagsgesellschaft. Erlangen, pp 75–81
Berger MR, Bischoff HH, Garzon FT, Schmähl D (1986) Autochthonous, acetoxymethylmethylnitrosamine-induced colorectal cancer in rats: a useful tool in selecting new active antineoplastic compounds? Hepato-Gastroenterology 33:227–234
Garzon FT (1985) Dissertation. University of Heidelberg, FRG
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Keller HJ, Keppler BK, Schmähl D (1982) Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butane-dionato)titanium(IV) compounds against Walker 256 carcinosarcoma. Arzneimittel Forsch 32 (II) 8:806–807
Keller HJ, Keppler BK, Schmähl D (1983) Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butane-dionato)titanium(IV) compounds. J Cancer Res Clin Oncol 105:109–110
Keppler BK, Diez A, Seifried V (1985) Antitumor activity of phenyl substituted dihalogenobis-(1-phenyl-1,3-butanedionato) titanium(IV) compounds. Arzneimittel Forsch 35 (II) 12:1832–1836
Keppler BK, Michels K (1985) Antitumor activity of 1,3-diketonato zirconium(IV) and hafnium(IV) complexes. Arzneimittel Forsch 35 (IV) 12:1837–1839
Keppler BK, Schmähl D (1986) Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium(IV) and budotitane. Arzneimittel Forsch 36 (II) 12:1822–1828
Kruskal WH, Wallis WA (1952) Use of ranks in one-cirterion variance analysis (I). J Am Stat Assoc 47:583–621
Kruskal WH, Wallis WA (1952) Use of ranks in one-criterion variance analysis (II). J Am Stat Assoc 48:907–911
Serpone N, Fay RC (1967) Stereochemistry and lability of dihalogenobis)β-diketonato)-titanium(IV) complexes. II. Benzoylacetonates and dibenzoylmethanates. Inorg Chem 6:1835–1843
Wagner I, Habs M, Schmähl D, Amberger H, Bachmann U (1982) Chemotherapeutic studies on N-nitrosoacetoxymethylmethylamine- and 1,2-dimethylhydrazine-induced colonic tumors in rats: Monotherapy with 5-Fluorouracil, Ftorafur, CGP 6809, and CGP 15'720A. J Cancer Res Clin Oncol 104:115–131
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Norbert Brock on the occasion of his 75th birthday
Rights and permissions
About this article
Cite this article
Bischoff, H., Berger, M.R., Keppler, B.K. et al. Efficacy of β-diketonato complexes of titanium, zirconium, and hafnium against chemically induced autochthonous colonic tumors in rats. J Cancer Res Clin Oncol 113, 446–450 (1987). https://doi.org/10.1007/BF00390038
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00390038